2024 Feb 6 [cited 2025 Jan 24]
Muller, P., Vousden, K.H.: Mutant p53 in cancer: new functions and therapeutic opportunities
These benefits appear to result from both weight loss and potential direct effects on blood vessel function
Inside the app, you'll get access to every tool and resource you need to be successful
A new LKB1 activator, piericidin analogue S14, retards renal fibrosis through promoting autophagy and mitochondrial homeostasis in renal tubular epithelial cells
Unlike pharmaceutical GLP-1 agonists, which can cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea, dietary approaches rarely produce significant adverse effects when implemented gradually